Benefits extended earlier in the coronavirus pandemic have been rolled back. But many older Americans are not taking advantage of the aid still available.

Now that the U.S. government has stepped back from issuing vaccines, long-term care operators have yet to start administering shots to protect one of the most vulnerable populations.

Readers offered theories of their own on a big budget mystery.

Instead of growing and growing, as it always had, spending per Medicare beneficiary has nearly leveled off over more than a decade.

Most Americans support lowering drug prices.

Readers assess Joe Biden’s accomplishments and shortcomings. Also: Drug price negotiations; a groundwater crisis; cancer, or not; training horses.

Lowering the prices of vital drugs is worthwhile, but innovation could suffer if the government isn’t careful.

A negotiation program is projected to save the government tens of billions of dollars in the coming years.

President Biden’s Inflation Reduction Act allows Medicare to negotiate some drug prices, a change that the pharmaceutical industry and Republicans have opposed for decades.

After his administration announced the first set of medications selected for Medicare price negotiations, President Biden vowed to continue standing up to the pharmaceutical industry over the cost of drugs.